about
Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model.Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery.Human red blood cells: rheological aspects, uptake, and release of cytotoxic drugs.Free ADP-ribose in human erythrocytes: pathways of intra-erythrocytic conversion and non-enzymic binding to membrane proteinsErythrocyte based delivery system of primaquine: in vitro characterization.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Encapsulation of adriamycin in human erythrocytes.
@en
Encapsulation of adriamycin in human erythrocytes.
@nl
type
label
Encapsulation of adriamycin in human erythrocytes.
@en
Encapsulation of adriamycin in human erythrocytes.
@nl
prefLabel
Encapsulation of adriamycin in human erythrocytes.
@en
Encapsulation of adriamycin in human erythrocytes.
@nl
P2093
P2860
P356
P1476
Encapsulation of adriamycin in human erythrocytes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.83.18.7029
P407
P577
1986-09-01T00:00:00Z